Peetz Christopher 4
4 · Mirum Pharmaceuticals, Inc. · Filed Mar 18, 2025
Insider Transaction Report
Form 4
Peetz Christopher
DirectorCHIEF EXECUTIVE OFFICER
Transactions
- Exercise/Conversion
Common Stock
2025-03-15+50,000→ 165,920 total - Sale
Common Stock
2025-03-17$44.21/sh−27,279$1,206,122→ 138,641 total - Exercise/Conversion
Performance Restricted Stock Units
2025-03-15−50,000→ 25,000 total→ Common Stock (50,000 underlying)
Holdings
- 208,570(indirect: By Trust)
Common Stock
Footnotes (3)
- [F1]Each performance restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
- [F2]Shares sold to cover tax withholding obligations associated with the vesting of the performance restricted stock units.
- [F3]The shares vest as follows: 2/3 of the shares vest on March 15, 2025 and 1/3 of the shares vest on March 15, 2026.